We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCN icon
801
DigitalOcean
DOCN
$15.3B
$581K 0.01%
+7,484
New +$463K
SILK
802
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$581K 0.01%
10,564
+5,135
+95% +$269K
MRO
803
DELISTED
Marathon Oil Corporation
MRO
$578K 0.01%
+42,254
New +$509K
AXSM icon
804
CALL
Axsome Therapeutics
AXSM
$11.4B
$577K 0.01%
+17,500
New +$682K
EVBN
805
DELISTED
Evans Bancorp Inc
EVBN
$577K 0.01%
+15,064
New +$580K
ADBE icon
806
PUT
Adobe
ADBE
$109B
$576K 0.01%
1,000
-2,100
-68% -$1.32M
FCAX.U
807
DELISTED
Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant
FCAX.U
$576K 0.01%
+58,911
New +$586K
TQQQ icon
808
CALL
ProShares UltraPro QQQ
TQQQ
$37B
$573K 0.01%
18,400
+1,600
+10% +$54.7K
HROW icon
809
Harrow
HROW
$1.52B
$565K 0.01%
62,197
+8,479
+16% +$76.7K
FMX icon
810
Fomento Económico Mexicano
FMX
$40.9B
$564K 0.01%
6,506
+3,306
+103% +$284K
PACB icon
811
Pacific Biosciences
PACB
$357M
$562K 0.01%
22,000
-41,300
-65% -$1.22M
PODD icon
812
Insulet
PODD
$9.91B
$561K 0.01%
1,974
-7,290
-79% -$2.08M
AXTA icon
813
CALL
Axalta
AXTA
$8.01B
$560K 0.01%
+19,200
New +$574K
EQC
814
DELISTED
Equity Commonwealth
EQC
$559K 0.01%
+21,500
New +$566K
ATC
815
DELISTED
Atotech Limited
ATC
$559K 0.01%
+23,127
New +$556K
ADUS icon
816
PUT
Addus HomeCare
ADUS
$2.23B
$558K 0.01%
7,000
QUAL icon
817
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$554K 0.01%
+4,208
New +$579K
POL.WS
818
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$554K 0.01%
329,882
+121,535
+58% +$193K
MACQ
819
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
$554K 0.01%
56,010
+3,135
+6% +$30.7K
DAL icon
820
Delta Air Lines
DAL
$58.7B
$553K 0.01%
+12,969
New +$529K
UI icon
821
Ubiquiti
UI
$34.5B
$552K 0.01%
1,847
+256
+16% +$79.1K
WFC icon
822
Wells Fargo
WFC
$265B
$552K 0.01%
+11,885
New +$550K
FSK icon
823
PUT
FS KKR Capital
FSK
$3.37B
$551K 0.01%
+25,000
New +$552K
CVX icon
824
Chevron
CVX
$382B
$550K 0.01%
+5,423
New +$541K
ICLR icon
825
Icon
ICLR
$12.8B
$550K 0.01%
+2,100
New +$510K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.